Kymera Therapeutics to report third-quarter financial results

KYMR•2026-10-28

Kymera Therapeutics will report third-quarter 2026 financial results and release results from its KT-579 Phase 1 healthy volunteer trial on Oct. 29, 2026.

1. Results due Oct. 29

Kymera Therapeutics will report third-quarter 2026 financial results and release results from the KT-579 Phase 1 healthy volunteer trial on Oct. 29, 2026. A video conference call and webcast will follow at 8:30 a.m. ET that day.

Kymera Therapeutics to report third-quarter financial results

1. Results due Oct. 29

Related News

NN raises 2026 adjusted EBITDA guidance to $64 million-$68 million

Chipotle presents ‘Recipe for Growth’ strategy in investor presentation

OGE Energy launches equity offering of up to $750 million

O'Reilly Automotive Q3 diluted EPS rises 14% to $0.97

Itron report finds technical integration hinders data-driven decisions at 53% of utilities